The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine
Ketamine (KET), a NMDA receptor antagonist, has been studied for its rapid and efficacious antidepressant effect, even for the treatment-resistant depression. Although depression is a major cause of disability worldwide, the treatment can be feasible, affordable and cost-effective, decreasing the po...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-06-01
|
| Series: | IBRO Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451830117300328 |